Acute Bilateral Anterior Uveitis following Cyclophosphamide/ Bortezomid/Dexamethasone (CyBorD) Protocol in a Newly Diagnosed Multiple Myeloma Patient with Concomitant Use of Zoledronic Acid
- 17 November 2021
- journal article
- letter
- Published by Taylor & Francis in Ocular Immunology and Inflammation
- Vol. 29 (7-8), 1328-1331
- https://doi.org/10.1080/09273948.2020.1745245
Abstract
Purpose: To report a case of anterior uveitis in a patient under treatment with Cyclophosphamide / Bortezomid / Dexamethasone (CyBorD) protocol for Multiple Myeloma and concomitant use of Zoledronic acid. Methods: Observational case report of a 50-year-old woman presenting with acute, severe, bilateral uveitis on a medical history of Multiple Myeloma, undergoing the first cycle of CyBorD protocol, including infusion with Zoledronic acid. Results: Continuation of therapy, with parallel treatment with topical and per os steroids led to resolution of the inflammation. Three more chemotherapy cycles were performed with the same protocol including Zoledronic acid at a lower dosage and were all, uneventful. Conclusion: Our case mirrored uveitis cases with either masquerade syndrome due to Multiple Myeloma or following Zoledronic acid infusion, despite concomitant usage of Dexamethasone and Cyclophosphamide. Three consecutive rechallenges were performed without any topical prophylactic treatment and with no relapse of signs or symptoms.Keywords
This publication has 6 references indexed in Scilit:
- Expression Profile of Cationic Amino Acid Transporters in Rats with Endotoxin-Induced UveitisMediators of Inflammation, 2016
- Proteasome Inhibitor Bortezomib Suppresses Nuclear Factor-Kappa B Activation and Ameliorates Eye Inflammation in Experimental Autoimmune UveitisMediators of Inflammation, 2015
- The Incidence of Acute Anterior Uveitis after Intravenous ZoledronateOphthalmology, 2013
- Anti-Inflammatory Effect of the Proteasome Inhibitor Bortezomib on Endotoxin-Induced Uveitis in RatsInvestigative Opthalmology & Visual Science, 2012
- Hypertensive Uveitis as a Feature of Multiple MyelomaOcular Immunology and Inflammation, 2010
- Cyclophosphamide for Ocular Inflammatory DiseasesOphthalmology, 2009